Microglia-mediated oxidative stress injury in a mouse model of Parkinson’s disease

doi:10.3969/j.issn.2095-4344.2013.11.015

Abstract

Abstract:

BACKGROUND: In microglia, inducible nitric oxide synthase can induce dopaminergic neurons to promote the intake of paraquat. However, exposure to paraquat can result in specific injury to dopaminergic neurons. The substantia nigra pars compacta in patients has activated microglia, but the role of oxidative stress injury is unkonwn.
OBJECTIVE: To explore the role of microglia mediated oxidative stress injury in mouse models of Parkinson’s disease.
METHODS: Thirty-six C57BL/6 mice were randomly divided into two groups with 18 mice in each: Parkinson’s disease group and control group. The model of Parkinson’s disease was established by intraperitoneal injection of paraquat to mice (10 mg/kg). The control group was given the same dose of normal saline as paraquat. Adult spontaneous motor activity was observed in the two groups. The level of dopamine in the substantia nigra pars compacta was observed by high-performance liquid chromatography. The expressions of tyrosine hydroxylase and mac-1 in the substantia nigra pars compacta were measured by immunohistochemical staining under optical microscope. The spectrophotometry was used to detect the activities of glutathione, superoxide dismutase and glutathione peroxidase and the content of malondialdehyde in the substantia nigra pars compacta.
RESULTS AND CONCLUSION: Parkinson’s disease group showed a marked hypoactive behavior and the number of microglia as compared with the control group (P < 0.05). Immunohistochemical staining showed tyrosine hydroxylase expression in the Parkinson’s disease group was decreased, but mac-1 was increased compared with the control group (P < 0.05). The content of dopamine in the substantia nigra pars compacta was lower than that in the control group detected by high-performance liquid chromatography (P < 0.05). The activities of glutathione, superoxide dismutase, and glutathione peroxidase were significantly reduced in the Parkinson’s disease group, but the content of malondialdehyde was increased as compared with the control group (P < 0.05). These findings indicate that activated microglia in the substantia nigra pars compacta can strengthen oxidative stress injury and weaken anti-oxidative protection, which may be an important pathogenesis of Parkinson’s disease.

Key words: tissue construction, cytology experiment in tissue construction, Parkinson’s disease, paraquat, microglia, tyrosine hydroxylase, superoxide dismutase, glutathione, glutathione peroxidase, malondialdehyde, oxidative stress, animal models, provincial grants-supported paper, tissue construction photographs-containing paper

CLC Number:

R318

Lu Ming-jia, Wang Shan-shan, Zhu Yi. Microglia-mediated oxidative stress injury in a mouse model of Parkinson’s disease[J]. Chinese Journal of Tissue Engineering Research, 2013, 17(11): 2001-2006.

Figures/Tables 4

References

[1] Katzenschlager R, Head J,Schraq A,et al.Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology. 2008;71:474-480.

[2] Mihara T,Mihara K,Yarimizu J,et al. Parmacological characterization of a novel, patent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropyridine-2(1H)-one(ASP5854),in models of Parkinson’s disease and cognition.J pharmacol Exp Ther. 2007;323(2):708-719.

[3] Chen P,Kales HC,Weintraub D,et al. Depression in veterans with Parkinson’s disease:frequency, comorbidity,and healthcare utilization.Int JGeriatr Psychiatry.2007;22 (6): 543-548.

[4] Uehara T, Nakamura T, Yao D, et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature.2006 ;441(7092) :513-517

[5] Liu B,Gao HM, Hong JS.Parkinson’s Disease and Exposure to infections Agents and pesticides and the Occurrence of Brain injuries:Role of Neuroin Ammation.Environ Health perspect (S0091-6765).2003;111:1065-1073.

[6] Sekiyama K, Sugama S, Fujita M,et al. Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies. 2012; 2012: 271732.

[7] McGeer PL, McGeer EG. Glial reactions in Parkinson’s disease. Mov Disord. 2008;23(4):474-483.

[8] Gao HM, Jiang J, Wilson B, et al. Microglial Activation-mediated Delayed and Progressive Degeneration of Rat Nigral Dopaminergic Neurons:Relevance to Parkinson’s Disease.J Neurochem(S0022-3042).2002; 81(6):1285-1297．

[9] Greenamyre JT,MackebziE GM,Peng TI,et al.Mitochondrial Dsyfunction in Parkinson’s Disease.Biochem soc symp (S0067-8694).1999;66:85-97.

[10] Kawai H,Makino Y,Hirobe M, et al.Novel ndogenous 1,2,3,4-tetrahydroisoquinoline derivatives:uptake by dopamine transporter and activity to induce parkinsonism. J Neurochem.1998;70:745-751.

[11] Dauer W,Przedborski S.Parkinson’s Disease:Mechanisms and Models.Neuron.2003;(6):889-909.

[12] Chen SD. Beijing：Renmin Junyi Chubanshe. 2002：238-239. 陈生弟.帕金森病临床新技术[M].北京：人民军医出版社,2002：238-239.

[13] Kim B, Yang MS, Choi D,et al.Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia. PLoS One. 2012; 7(4): e34693.

[14] Block ML, Hong JS. Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans. 2007;35 ( Pt5):1127-1132.

[15] Kim YS,Joh TH.Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson’s disease.Experimental and Molecular Medicine.2006;38(4): 333-347.

[16] Lee EJ, Woo MS, Moon PG,et al.α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1. J Immunol. 2010;185(1): 615-223.

[17] Kim WG,Mohney RP,Wilson B,et al.Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain:role of microglial J Neurosci.2000;20:6309-6316.

[18] Huh SH, Chung YC, Piao Y,et al.Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease. J Immunol. 2011;187(2):960-969.

[19] Kreutzverg GW. Microglia: a sensor for pathological events in the CNS.Trends Neurosci.1996;19:312-318.

[20] Kumar H, Lim HW, More SV,et al.The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism. Inter J Molecular Sci. 2012;13, 10478-10504.

[21] Xu JP,Li YL,Lin XY,et al.Zhongfeng yu Shenjing Jibing Zazhi. 2000;17(1):46-48.许继平,李玉莲,蔺新英,等.帕金森病患者血液抗氧化功能的变化及多巴制剂与VitE对其影响的研究[J].中风与神经疾病杂志, 2000, 17(1):46-48.

[22] Ren JP,Sun XJ,Jiang YP.Shanghai Jiaotong Daxue Xuebao: Yixueban. 2007;27 (1):76-78.任今鹏,孙晓江,蒋雨平.百草枯对小鼠黑质多巴胺能神经元氧化应激的影响[J].上海交通大学学报：医学版, 2007, 27 (1):76-78.

[23] David R Beers,Weihua Zhao,Bing Liao,et al. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice Brain Behav Immun. 2011; 25(5): 1025–1035.

[24] Raivich G.Like cops on the beat:the active role of resting microglia. TrendsNeurosci.2005;19:312-318.